Member Info for B2HS2L

...If they don't purchase the 700 instruments, they won't need so many test kits :(

Peka, - you forgot about the 700 instruments that might feature in the contract extension!

£9.3 Million - 12500 Genesig Covid-19 kits for Ministry of Security Ukrain

$13.5 Million (£9.854 million as @ todays exchange rate) - WHO order for 1.2 million tests to Ukrain

...and the Company is in active discussions with the DHSC to extend this phase of the 29.09.2020 contract.

Gross margin for the full year above 80%.

This news on top of todays EBITDA profitability for the full year above €210 million (£187 million), with H2 2020 EBITDA above €161 million (£143 million)

Therefore H2 2020 EBITDA above £143 million, = £785,000 / day = current rate of Earnings before Interest, Tax, Depreciation & Amortisation

Gross margin for the full year above 80%, - not likely to drop off in 2021 :)

P/E due a review!

Market gradually absorbing that testing requirement is going to remain high for 2021.

++++

All means sp heading north from here me thinks, but it will take a while for true value to be identified by the market.

https://www.cultek.com/catalogsearch/result/?q=genesig

Erica D'Angelo's press release refers to the company as Primer Design as per my 11:19 post Brent ;)

Brentw1 -
Primer Design,
not Primerdesign?

A basic error

A previous press release states:

Novacyt COVID-19 Diagnostic tests remain able to detect all published virus strains

by Erica D'Angelo January 14, 2021

AFSBio is proud to partner with Novacyt Group/Primer Design for North America to offer their SaRS-COV-2 (FDA/EUA approved) and SaRS-COV2 Winterplex assays. Both CE-IVD certified.

They test for both ORF1ab and the S gene with 100% specificity. The Winterplex assay also includes Influenza A, B, and RSV.

Their latest press release shows that both tests can still detect the new COVID-19 variant by the UK's COVID-19 Genomics UK consortium, known as VUI-202012/01 with the same high level of accuracy.

Novacyt notes this new strain of the virus has also been identified in other countries, including the Netherlands, Denmark, and Australia.

https://afsbio.com/blogs/news/novacyt-covid-19-diagnostic-tests-remain-able-to-detect-all-published-virus-strains

and:

About AFSBio

As a leading distributor of life science equipment and reagents, AFSBio works with Canadian researchers, hospitals, and biopharma companies seeking to increase efficiencies, reduce costs, and streamline their workflow in the lab.

Quick questions:
1 is FDA EUA recognised in Canada?
2 Is CE-IVD recognised in Canada?

Some MEA countries (Saudi) recognise CE-IVD in much the same way as any EU country would.

Dry Ice used to ship PROmate though Shaun, (if I recall correctly from the video).
Somebody mooted that because the IFU is not available on the website, that DHSC is the only customer.
(COVID H-T IFU is also not available, and thought to be because Cambridge partnership is the only customer).

Sounds likely to me.

Jungla,

If results are well above previous broker estimates, won't they be obliged to pull their finger out, as the market will want as much info as possible like yesterday, particularly about whether this level of business is sustainable.

Hi Wilson,

Turning over this much business means that 8-5 is long gone.
With the world it's oyster, I would imagine business is being conducted on a 3 shift system, or at least 6-2 / 2-10!
What do you think?

Ref my 19:16 post

Either
1 Primerdesign is no longer using hard to find materials for Z-Path-COVID-19-CE.
2 Primerdesign has access to these materials in such quantities that filling a 1.2 million order with
Z-Path-COVID-19-CE is not a problem.

A quick response from Primerdesign identifies that 2 is true.

The United Nations Children's Fund (UNICEF) has purchased 1.2 million COVID-19 PCR tests for Ukraine.

The test that has been purchased is Z-Path-COVID-19-CE, as per the WHO Emergency Use Listing for In vitro diagnostics (IVDs)
https://extranet.who.int/pqweb/sites/default/files/documents/210126_eul_sars_cov2_product_list.pdf

So this is the kit that utilised some hard to find materials, and thus Primerdesign brought out the Exsig-Direct test that did not use those materials.

Either
1 Primerdesign is no longer using hard to find materials for Z-Path-COVID-19-CE.
2 Primerdesign has access to these materials in such quantities that filling a 1.2 million order with
Z-Path-COVID-19-CE is not a problem.

I plugged in the Z-Path-COVID-19-CE part number into the Genesig website and found the IFU is currently
at ISSUE 5, 22nd September 2020.

I will be contacting Primerdesign to establish whether 1 or 2 is true.

Most of the new IFU issues are caused by a change to sample types / Extraction Platforms or PCR platforms.

My apologies Bing, you did post it yesterday.

Bump
https://www.youtube.com/watch?v=SfBWanjuTKk

https://www.youtube.com/watch?v=SfBWanjuTKk

Apologies if already posted

High Shaun,

Another supplier for your spreadsheet:

Finland:

AH Diagnostics, - https://www.ahdiagnostics.fi/

supplying Z-PATH-COVID-19-CE (Z-Path-COVID-19-CE)

https://indd.adobe.com/view/b847c202-6637-47b4-97cc-fa2d58e60f80 (catalogue, page 17 refers)

CS - Suggest you change your name to 'It's all about me'
Reported for disruption.

EXMEX -

From 16.11.2020 R&D UPDATE RNS:

"The Company is also in active discussions with several potential partners who are seeking support to develop, manufacture and supply LAMP tests for their instrument platforms."
+++

From your last post - "All it needs now is a more sensitive assay".

Does this tie in ENOUGH do you think?

I would say on balance affirmative.

Wilson, - I don't have that problem, - I put more hairdressers out of business than I care to mention.

Slapheads unite!

They are not the same Samba's Hartlebury.

Surely Diagnostics for the Real World would know about the other Samba?